Literature DB >> 31938104

Rab5a promotes the migration and invasion of hepatocellular carcinoma by up-regulating Cdc42.

Xiao Yang1, Zhengshu Liu2, Yongguo Li3, Ke Chen1, Hong Peng1, Liying Zhu1, Huihao Zhou1, Ailong Huang1, Hua Tang1.   

Abstract

There are many factors participating in the process of human hepatocellular carcinoma (HCC) occurrence and development. In this study, romoted cell invasion and migration in vitro and in vivo. In contrary, inhibition of Rab5a suppressed cell invasion and migration. Mechanistic studies revealed that Rab5a was positively regulated cell division cycle 42we found that Rab5a expression was higher in the HCC tissues and 3 cell lines than normal liver tissues. Overexpression of Rab5a p (Cdc42) expression by enhancing its promoter activity. These data suggested that Rab5a is highly expressed in HCC, and promote the invasion and migration by targeting Cdc42 expression. IJCEP
Copyright © 2018.

Entities:  

Keywords:  Cdc42; HCC; Rab5a; invasion; migration

Year:  2018        PMID: 31938104      PMCID: PMC6957975     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  3 in total

1.  Overexpression of Rab40b Promotes Hepatocellular Carcinoma Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway.

Authors:  Li-Wei Shi; Zhi-Bo Zhao; Li Zhong; Jian Gao; Jian-Ping Gong; Hang Chen; Yu Min; Yi-Yin Zhang; Zhi Li
Journal:  Cancer Manag Res       Date:  2020-10-14       Impact factor: 3.989

2.  Identification of Key Genes Associated with Endothelial Cell Dysfunction in Atherosclerosis Using Multiple Bioinformatics Tools.

Authors:  Guofu Zhang; Hui Yu; Jingjing Su; Chao Chi; Lide Su; Fenglin Wang; Ying Zheng; Baodong Xie; Kai Kang
Journal:  Biomed Res Int       Date:  2022-01-10       Impact factor: 3.411

3.  Hsa_circ_0001756 promotes ovarian cancer progression through regulating IGF2BP2-mediated RAB5A expression and the EGFR/MAPK signaling pathway.

Authors:  Jing Ji; Chen Li; Jinfeng Wang; Lei Wang; Huifang Huang; Ying Li; Jing Fang
Journal:  Cell Cycle       Date:  2022-02-03       Impact factor: 5.173

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.